Andre Abreu, MD, presented “Energy Selection Ablative Technologies for Focal Therapy” during the 2024 Frontiers in Oncologic Prostate Care and Ablative Local Therapy symposium on October 17, 2024, in San Diego, California.
>
How to cite: Abreu, Andre. “Energy Selection Ablative Technologies for Focal Therapy.” October, 2024. Accessed Jan 2025. https://grandroundsinurology.com/energy-selection-ablative-technologies-for-focal-therapy/
Energy Selection Ablative Technologies for Focal Therapy – Summary
Andre Abreu, MD, delves into energy modalities for focal therapy in prostate cancer, presented with a comprehensive and practical approach. This 16-minute presentation explores multiple energy options, including cryoablation, high-intensity focused ultrasound (HIFU), irreversible electroporation (IRE), laser ablation, and microwave ablation. Dr. Abreu emphasizes the importance of aligning energy selection with institutional expertise and patient-specific factors.
Patient-specific considerations guide technology selection, including rectal wall thickness and proximity to critical structures. Transition zone lesions benefit from tools like aqua ablation, while anterior lesions present challenges for certain devices. The speaker emphasizes the need for personalized management, integrating oncologic characteristics with procedural capabilities.
Dr. Abreu optimistically frames the future of focal therapy, with ongoing trials like vapor ablation and the potential for low-dose radiation therapy combined with IRE promising advancements. He calls for practical recommendations and an invitation for ongoing exploration in the evolving field of prostate cancer management.
Frontiers in Oncologic Prostate Care and Ablative Local Therapy (FOCAL) is an outstanding program on prostate imaging, transperineal interventions, and ablative treatments for prostate cancer and benign prostatic hyperplasia. Bringing together community-based, academic, and industry partners, FOCAL offers lectures by world-renowned faculty and hands-on training workshops on in-office transperineal interventions, fusion-guided prostate ablation and state-of-the-art BPH management with novel technologies.
ABOUT THE AUTHOR
Dr. Andre Abreu is a urological surgeon and urologist, currently practicing at the Keck Hospital of the University of Southern California in Los Angeles, CA. He earned his M.D. from the Universidade Federal do Ceará Faculdade de Medicina, where he also completed an internship. Dr. Abreu then completed his urology residency at the Hospital São Lucas da PUCRS in Brazil, followed by a fellowship in minimally-invasive surgery at the Keck Hospital of the University of Southern California. Current affiliations include Verdugo Hills Hospital, the Keck Hospital of USC, and USC Norris Cancer Hospital.
He is well-versed in both English and Portuguese and has contributed to several published works focusing on a variety of subjects, including analyses of robot-assisted surgery techniques, the utility and accuracy of MRI and ultrasound technology, and the limitations of computed tomography for renal tumors.
